| Financial Year |
March 31 2023 |
| Monetary Funds |
70,402,049.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
130,000.00 |
| Accounts Receivable |
162,440,678.86 |
| Advances to Suppliers |
7,628,338.72 |
| Other Receivables |
17,060,802.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,826,073.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
112,365.55 |
| Other Current Assets |
12,725,703.39 |
| Total Current Assets |
273,326,012.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,905.36 |
| Long-term Equity Investment |
76,196,650.94 |
| Investment Properties |
-- |
| Fixed Assetes |
109,056,333.02 |
| Under-construction Projects |
37,280,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,631,347.22 |
| R&D expenses |
1,399,582.81 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,293,166.60 |
| Deferred Income Tax Assets |
7,077,673.44 |
| Other Non-Current Assets |
1,515,900.00 |
| Sub-Total of Non-Current Assets |
392,601,904.23 |
| Total Assets |
665,927,916.73 |
| Short-Term Loans |
210,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
93,461,602.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,266,478.33 |
| Taxes Payable |
2,298,220.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,625,917.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
57,168,461.39 |
| Other Current Liabilities |
7,785.41 |
| Sub-Total of Current Liabilities |
400,283,388.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
159,663,620.98 |
| Deferred Income Tax Liabilities |
1,063,756.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
230,678,004.95 |
| Total Liabilities |
630,961,393.42 |
| Paid-In Capital(Or Share Stock) |
446,687,115.00 |
| Capital Surplus |
757,555,772.58 |
| Surplus Reserve |
18,425,538.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,206,565,154.73 |
| Minority Stockholder's Interest |
24,593,801.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,372,721.81 |
| Owner's Equity（Stockholder's Equity） |
34,966,523.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
665,927,916.73 |
